期刊文献+

宫颈癌疫苗推广应用前景分析 被引量:2

原文传递
导出
摘要 宫颈癌是全球女性最常见的恶性肿瘤,近年来,发病率、死亡率均有所上升,已成为严重危害女性健康和生命的主要癌症之一,同时,也是第一个能用疫苗预防的癌症。预防性宫颈癌疫苗已于2006年在美国上市,目前已推广应用到世界160多个国家和地区,收到了显著的预防效果,但中国大陆地区至今没有推广应用。文中对当前应用的两种宫颈癌疫苗的有效性、安全性、保护作用等进行了概述,对我国推广应用的优势进行了分析,并提出了相关建议。
作者 常永生
出处 《社区医学杂志》 2014年第16期78-79,共2页 Journal Of Community Medicine
  • 相关文献

参考文献8

  • 1章文华.子宫颈癌防治展望[J].癌症进展,2010,8(2):105-108. 被引量:29
  • 2孟庆普.我国宫颈癌发病率世界第二[EB/OL].(2014-03-17)[2014-03-29].http://www.jkb.com.cn/news/technology/2014/0317/327321.html.
  • 3张洁.默沙东宫颈癌疫苗获FDA批准上市[N].中国劳动保障报,2006-06-30(3).
  • 4郑智敏.佳达修成为首个获世卫组织资格预审的宫颈癌疫苗[N].医药经济报,2009-06-11(8).
  • 5项铮.宫颈癌疫苗将成为主要预防手段[N].科技日报,2010-07-01(11).
  • 6林岚.宫颈癌HPV疫苗的应用进展[J].天津药学,2010,22(6):66-69. 被引量:3
  • 7王福丽.葛兰素史克:宫颈癌疫苗获预认证[N].健康时报,2009-07-23(23).
  • 8张旭.葛兰素史克公司宫颈癌疫苗获FDA批准[N].中国医药报,2009-11-19(B6).

二级参考文献22

  • 1Padilla-Paz L A.Human papillomavirus vaccine:history,immunology,current status,and future prospects.Clin Obstet Gynecol,2005,48:226.
  • 2Ban E,Tamms G.Quedrivalent human papiliomavirus vaccine.Clin Infect Dis,2007,45:609.
  • 3Paavonen J.Future Ⅱ study group:baseline demographic characteristics of subjects enrolled in international quadrivalent HPV(types 6/11/16/18)vaccine clinical trials.Curr Med Bes Opin,2008,24:1623.
  • 4FUTURE Ⅱ Study Group.Prophylactic effi cacy of a quadrivalent human papillomavirus(HPV)vaccine in women with virological evidence of HPV infection.Journal of Infectious Diseases,2007,196:1438.
  • 5Paavonen J L.HPV PATRICIA study group:effi cacy of a prophylactic edjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:an interim analysis of a phase Ⅲ doubie-blind,randomised controlled trial.Lancet,2007,369:2161.
  • 6Ferris D.For the FUTURE Ⅰ and Ⅱ study group:presented at:2008 Biennial Meeting of the American Society for Colposcopy and Cervical Patholagy.Orlando,2008,20:17.
  • 7Pagliusi S R,Aguaclo M T.Efficacy and other milestones for human papillomavirus vaccine introduction.Vaccine,2004,23:569.
  • 8Brown D R,Shew M L,Qadadri B,et al.A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.j Infect Dis,2005,191:182.
  • 9Francnschi S,Herrero B,Clifford G M,et al.Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.Int J Cancer,2006,119:2677.
  • 10Paavonen J.HPV PATRICIA study group.Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:an interim analysis of a phase Ⅲ doubie-blind,randomized controlled trial Lancet,2007,369:2161.

共引文献30

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部